Regional differences in astrocyte activation in HIV-associated dementia

Area of Science:

• Neuroscience
• Neuropathology
• Immunohistochemistry

Background:

• Astrogliosis, indicated by glial fibrillary acidic protein (GFAP) expression, is a known hallmark of HIV-associated dementia (HIV-D).
• The precise relationship between GFAP expression patterns and regional brain pathology in HIV-D requires further elucidation.

Purpose of the Study:

• To investigate the correlation between glial fibrillary acidic protein (GFAP) expression and the regional distribution of activated astrocytes in HIV-associated dementia (HIV-D).
• To determine the most reliable method for quantifying astrogliosis in HIV-D brain tissue.

Main Methods:

• Immunohistochemical staining of brain tissue sections from HIV-D patients and age-matched controls using antibodies against GFAP.
• Quantification of GFAP-positive (GFAP+) astrocyte cell numbers and surface density in various brain regions.

Main Results:

• Significantly increased mean numbers of GFAP+ astrocytes were observed in the entorhinal cortex, hippocampus, and subcortical white matter of HIV-D patients compared to controls.
• Frontal cortex and basal ganglia showed similar astrocyte numbers between HIV-D patients and controls.
• A consistent and significant increase in the surface density of immunoreactive GFAP was detected in all tested brain areas of HIV-D patients, including the entorhinal cortex and hippocampus.

Conclusions:

• Quantification of GFAP+ cell surface density is a more sensitive and reliable indicator of gliosis in HIV-D than counting astrocyte nuclei.
• Regional variations in astrocyte activation suggest differential contributions to neuropathogenesis in HIV-D.
• Understanding regional astrocyte reactivity is crucial for deciphering the neuropathogenesis of HIV-D and other neurodegenerative disorders.